Medable introduces Medable Studio, a revolutionary application that simplifies and accelerates the process of configuring, translating, and launching eClinical Outcome Assessments (eCOA Plus). This all-in-one solution combines a user-friendly interface with powerful design capabilities, empowering users to create protocol-fit studies in several hours instead of months.
Medable Studio’s no-code suite eliminates the complexities of traditional eCOA launch processes. Biopharmaceutical companies have enhanced control and transparency, leading to faster study go-live and earlier patient enrollment. The self-service, full-service, or hybrid options offer flexibility and cost-effectiveness.
Medable Studio disrupts the industry by offering a technology-first solution. It transforms the opaque process of eCOA into a transparent one, providing sponsors with greater control and speed. This breakthrough eliminates the dependence on professional services, reducing timelines from weeks and months to days.
Studio’s comprehensive suite of features includes:
• Protocol-fit study designs for precision in clinical trials
• Intuitive interface for non-technical users to seamlessly build and launch complex studies
• Cloud-based platform for up-to-date capabilities and real-time collaboration
Medable Studio empowers trial teams to create protocol-fit science with greater scalability and efficiency. By reducing trial start-up timelines and costs, this innovative solution paves the way for faster delivery of effective therapies to needy patients.
Medable Studio is now available as part of Medable’s software-as-a-service platform. This platform has been deployed in over 300 clinical trials, serving millions of patients globally. Customers have experienced notable improvements, including accelerated enrollment and reduced costs.
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
